ClinicalTrials.Veeva

Menu

Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia

U

University of Rome Tor Vergata

Status

Unknown

Conditions

Lower Urinary Tract Symptoms
BPH

Treatments

Device: Transperineal Focal Laser Ablation (TPLA)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study investigated the effectiveness and safety of SoracteLite ™- Trans-Perineal Laser ablation (TPLA) in the treatment of patients with symptomatic Benign Prostatic Hyperplasia (BPH) at 6 and 12 months follow-up

Full description

The purpose of this study was to investigate the effectiveness and safety of SoracteLite ™ - Trans-Perineal Laser ablation (TPLA) in the treatment of patients with symptomatic benign prostatic hyperplasia (BPH) at 6 and 12 months follow-up. Methods: Patients with urinary symptoms secondary to BPH underwent TPLA under local anaesthesia in four centers. Under US guidance, up to four 21G applicators were inserted in the prostatic tissue. Each treatment was performed with diode laser operating at 1064 nm changing the illumination time according to prostate size.

Enrollment

160 patients

Sex

Male

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male
  • ≥ 50 years of age
  • International Prostate Symptoms (IPSS) ≥12
  • Peak urinary flow rate (Qmax): <15 ml
  • Prostate volume: ≥ 30 ml, measured by transrectal ultrasound
  • Post-void residual (PVR): <400 ml
  • Signed informed consent

Exclusion criteria

  • MRI signs of malignancy confirmed by biopsy investigation
  • urethral stenosis
  • serious coagulation disorders
  • inadequate compliance
  • ischemic pathology in the previous six months
  • active phase inflammatory pathology

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

160 participants in 1 patient group

SoracteLite
Experimental group
Description:
Transperineal Focal Laser Ablation (TPLA)
Treatment:
Device: Transperineal Focal Laser Ablation (TPLA)

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems